VIVID LIFE SCIENCES, LLC – Trademark Portfolio
Entity Type: 16
VIVID LIFE SCIENCES, LLC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 10 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include VIGEO, GENMAX, VIVID LIFE SCIENCES, and BRIGHTER IDEAS IN PLANT PERFORMANCE. The owner is based in Princeton, MN.
31932 136th Street
Princeton, MN 55371
Showing of trademarks Trademarks
Trademark Classifications
VIVID LIFE SCIENCES, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does VIVID LIFE SCIENCES, LLC have?
VIVID LIFE SCIENCES, LLC has 11 U.S. trademarks filed with the USPTO. Of these, 5 registered, 4 abandoned, 2 cancelled.
What trademark classes does VIVID LIFE SCIENCES, LLC file in?
VIVID LIFE SCIENCES, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are VIVID LIFE SCIENCES, LLC's most well-known trademarks?
VIVID LIFE SCIENCES, LLC's registered trademark portfolio includes well-known marks such as VIGEO, GENMAX, VIVID LIFE SCIENCES, and BRIGHTER IDEAS IN PLANT PERFORMANCE. These are among 5 currently registered trademarks in the portfolio.
What is VIVID LIFE SCIENCES, LLC's trademark registration success rate?
VIVID LIFE SCIENCES, LLC has a 45% trademark registration rate, with 5 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.